Avant Group (3836) · RiskExclusion from the Equity-Method Scope
Metapraxis Limited's Weak Performance and Investment Impairment
First written in FY2022. 1 of 2 entries say "Materialised", first in FY2022. Latest entry: FY2024.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Impairment of Investments in Overseas Equity-Method Joint Ventures and Associates and Equity-Method LossesA theme 16 companies write about · 18 as a headwind · 0 as a tailwind
The whole theme swung hardest in 2019: 3 of 8 companies on the "Worse" side.
0 other companies' latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 16 companies compared. The sentences above are computed from all 16.Full recordFilings, disclosures and news, newest first
- FY2024Exclusion from the Equity-Method ScopeAnnual report
「Metapraxis Limited was excluded from the scope of application of the equity method during the current consolidated fiscal year because the Company no longer had significant influence.」
Metapraxis Limited, whose weak performance and impairment had been disclosed, was excluded from the scope of application of the equity method in the current fiscal year because the Company no longer had significant influence. - FY2022MaterialisedAnnual report
「The performance of Metapraxis in the UK and US had failed to recover adequately since COVID-19 became widespread and was significantly below the assumptions made when the Company invested. As its financial position was also below a certain level, the Company recognised an impairment loss on the shares of the equity-method investee.」
For Metapraxis Limited, recognised an impairment loss of ¥181.221 million, equivalent to goodwill, as a loss on investments accounted for using the equity method, reflecting performance and financial position significantly below the assumptions made at the time of investment. Meanwhile, stated that product sales and implementations in the Japanese market were beginning to gain traction.